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ABSTRACT 
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Heart failure (HF) is a syndrome resulting from a complex genetic predisposition and 
multiple environmental factors: it is a leading cause of morbidity and mortality. Specific 
gene expression patterns are activated in the hypertrophic and failing heart and are 
thought to contribute to the development of HF. Many regulatory molecules are 
involved in the control of gene expression: among these, long non-coding RNA (lncRNA) 
is gaining importance for several cellular process and diseases. However, little is still 
known about its involvement in HF. Many functions have been attributed to lncRNAs, 
such as cell proliferation, apoptosis and cell invasion, indicating that they may represent 
a major regulatory component of the eukaryotic genome. Not surprisingly, lncRNAs have 
been found implicated in several aspects of cancer, and in many neuronal diseases. 
Despite this, and the known role of other ncRNAs, such as miRNA, in HF, the function of 
lncRNAs in this pathologic state has been not studied. Thus, the general hypothesis 
behind this project is that lncRNAs have an important role in defining gene expression re-
programming in HF. Consequently, the overall scientific objective of this proposal is to 
study the role of lncRNAs in gene transcription regulation accompanying heart failure. To 
this end, we propose to use high-throughput RNA sequencing (RNA-seq) to identify 
lncRNAs that are modulated in cardiomyocytes during HF. In order do to this, we 
performed RNA-seq on cardiomyocytes isolated from mice after 1, 2, 4 and 7 days of 
transverse aortic constriction (TAC) and from sham-operated mice. The importance of 
this study lies not only in the furthering of our understanding of the pathological 
mechanisms leading HF, but aims to generate – in the light of recent progress in RNA-
based therapeutic strategies – data that may be instrumental to the development of 
improved therapeutic strategies for this increasingly frequent pathology. 
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INTRODUCTION
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1.1- Heart Failure 
Heart failure (HF) is not only a leading cause of morbidity and mortality (Ahmad et al., 
2012), it is the ultimate outcome of many cardiovascular pathologies. It is underlain by 
gene expression and epigenetic reprogramming, wherein certain fetal genes are 
upregulated while adult genes become downregulated (Izumo et al., 1988, Lompre et al., 
1979). 
Heart failure may be due to cardiac hypertrophy, an adaptive response to pressure or 
volume stress. Hypertrophic growth is the cause of many forms of heart disease, such as 
hypertension, ischemic disease, valvular disease, and heart failure. The hypertrophic 
mechanism is the way in which cardiomyocytes respond to mechanical stress, enabling 
myocytes to increase their work output and improve cardiac pump function (Figure 1). 
Ventricular hypertrophy is therefore associated with a high risk of heart failure (Levy et 
al., 1990) (Koren et al., 1991). 
The hypertrophic transformation of heart has been divided in the past (Meerson, 1961) 
in 3 steps: 
1) Stage in which load exceeds output, developing hypertrophy 
2) Stage which the workload/mass ratio is normalized, compensatory hypertrophy  
3) Stage characterized by ventricular dilation and subsequent heart failure 
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Figure 1. The picture shows the difference in size and structure between normal and hypertrophic 
heart. 
 
Furthermore, cardiac hypertrophy, a pathological event that is ultimately responsible for 
a deterioration in heart function, is principally due to gene reprogramming. It has been 
discovered that mechanisms similar to those that govern gene expression in heart 
development (and maturation) are at the basis of those that occur in HF (Hunter & 
Chien, 1999). The study of the mechanisms that control cardiac gene expression in HF 
and heart development provides information conducive to the better understanding of 
HF pathogenesis, and could lead to new diagnostic and therapeutic tools (Han et al., 
2011).  
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1.2- ncRNAs 
One of the greatest surprises obtained during the last years has been the discovery of 
noncoding RNAs (ncRNAs) with high-throughput analysis of the transcriptome. ncRNA 
are a variety of RNA that are not translated into a protein and act at the level of 
transcription or translation and influence gene expression through various 
mechanisms—such as RNA interference. Based on size, ncRNAs can be divided into two 
groups (Table1): (1) small ncRNAs (<200nt), which include microRNA (miRNA), PIWI-
interacting RNA (piRNA), and endogenous small interfering RNA (siRNA), and (2) long 
ncRNAs (lncRNAs), which have a length between 0.2 and 2 kb and, thus, a coding 
potential of less than 100 amino acids (Mitra et al., 2012, Qureshi & Mehler, 2012, 
Saxena & Carninci, 2011, Wang & Chang, 2011). 
 
tRNA/mt-tRNA 
Transfer RNA & 
mitochondrial 
transfer RNA 
It is an adaptor molecule composed of RNA, 
typically 73 to 94 nucleotides in length, that 
serves as the physical link between the 
nucleotide sequence of nucleic acids (DNA and 
RNA) and the amino acid sequence of 
proteins. 
rRNA/mt-rRNA 
Ribosomal RNA & 
mitochondrial 
ribosomal RNA 
It is the RNA component of the ribosome, and 
is essential for protein synthesis in all living 
organisms 
scRNA Small cytoplasmic 
RNA 
Small (7S; 129 nucleotides) RNA molecules 
found in the cytosol and rough endoplasmic 
reticulum associated with proteins that are 
involved in specific selection and transport of 
other proteins. 
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snRNA Small nuclear 
A general term for many different kinds of 
small RNA molecules found in the nucleus of a 
cell that include as examples species involved 
in splicing of introns from mRNA and in RNA 
interference. 
snoRNA 
Small nucleolar 
They are a class of small RNA molecules that 
primarily guide chemical modifications of 
other RNAs, mainly ribosomal RNAs, transfer 
RNAs and small nuclear RNAs. 
piRNA piwi RNA 
piRNAs guide PIWI proteins to complementary 
RNAs derived from transposable elements. 
Similarly to in RNA interference, PIWI proteins 
cleave the transposon RNA, leading to 
silencing. 
miRNA microRNA 
Small RNAs containing 21 to 33 nucleotides 
that associated with multiple proteins in a 
RNA-induced silencing complex (RISC) that 
repress transcription of specific target mRNA 
by hybridizing to its 3' untranslated region. 
siRNA small interfering 
It is a class of double-stranded RNA molecules, 
20-25 base pairs in length. siRNA plays many 
roles, but it is most notable in the RNA 
interference (RNAi) pathway 
lncRNA long non coding RNA 
Large intergenic non-coding RNAs, usually 
associated with open chromatin signatures 
such as histone modification sites. Could be 
divided in different categories according to 
their genomic position and have multiple 
functions. 
 
Table 1. The table shows the different classes of small non coding RNA and long ncRNA. 
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So far, a large range of functions have been attributed to ncRNA, such as cell 
proliferation, apoptosis, and cell invasion and imprinting, indicating that these molecules 
may represent a major regulatory component of the eukaryotic genome. Not 
surprisingly, ncRNAs are emerging as important players in several human pathologies, 
including cardiovascular diseases (Mitra et al., 2012, Qureshi & Mehler, 2012, Saxena & 
Carninci, 2011, Wang & Chang, 2011). Indeed, miRNAs play a key role in driving the gene 
expression changes of HF, atherosclerosis, and cardiac ischemic/reperfusion injury 
(Latronico & Condorelli, 2009). However, we are just beginning to understand the 
biology of piRNA, siRNA, and lncRNA in the cardiovascular system.  
 
1.3- Biological Roles of lncRNAs 
lncRNAs are currently defined as transcripts greater than 200 nt without known protein-
coding function (Batista & Chang, 2013). Though thousands of lncRNAs have been 
identified across eukaryotes, many appear less conserved than protein-coding genes and 
therefore seems to be species specific (Cabili et al., 2011, Derrien et al., 2012). lncRNAs 
can be classified into one or more of the following five categories, based on their 
genomic distribution, (Figure 2): (A) sense, the lncRNA sequence overlaps with the sense 
strand of a protein coding gene; (B) intronic, the lncRNA sequence is derived entirely 
from within an intron of another transcript; (C) bidirectional, the lncRNA is located on 
the opposite strand from a protein coding gene whose transcription is initiated less than 
1000 base pairs away; (D-E) antisense, the lncRNA sequence overlaps with the antisense 
strand of a protein coding gene; and/or (F) intergenic, the lncRNA sequence is not 
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located near any other protein coding loci. Although only a very small percentage of 
identified lncRNAs have been explored experimentally, they are known to be implicated 
in many biological processes such as cell fate specification, X chromosome inactivation, 
nuclear compartmentalization and architecture, genomic imprinting, translational 
control, RNA splicing and chromatin modification (Wutz & Gribnau, 2007).  
 
Figure 2. The picture shows the genomic position of lncRNA, (A)Sense, (B) Intronic, (C) Bidirectional, 
(D,E) Exonic/Intronic Antisense, (F) Intergenic. 
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1.3.1- X chromosome Inactivation and Genomic Imprinting  
Xist is one of the best-studied lncRNAs. It was discovered in 1991 and now it is widely 
accepted to be required for the silencing of hundreds of genes on the inactive X 
chromosome in female somatic cells by favouring the formation of a chromatin structure 
with an epigenetic profile linked to transcription repression. This process is known as X 
chromosome inactivation (XCI) (Figure 3) (Heard et al., 2001). However the exact 
mechanism of Xist-mediated XCI is yet to be fully elucidated, despite having been studied 
extensively (Wutz & Gribnau, 2007). lncRNAs are also implicated in genomic imprinting, a 
process that inactivates either the maternally or the paternally inherited allele. 
Imprinted genes play crucial roles in mammalian development, and so their expression 
must be highly regulated. Intriguingly, many imprinted gene loci express, in addition to 
mRNAs, a significant number of lncRNAs (e.g., Air, H19, and Kcnq1ot1) that appear to 
play major roles in regulating the expression of neighbouring imprinted protein coding 
genes in cis (Reik & Murrell, 2000).  
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Figure 3. Model of Xist Inactivation: A, blocking factors prevent Xist RNA, expressed in an unstable 
form (dotted red lines), the association with the chromosome in cis. B, through stabilization Xist RNA 
becomes upregulated and release of the blocking factor. C, Xist RNA coats the X chromosome. D, Xist 
RNA coating cause transcriptional silencing of genes on the X chromosome. E, chromatin 
modifications, transform the Xist RNA-coated chromosome into a stably inactive and condensed 
chromatin state (Avner & Heard, 2001). 
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1.3.2- Nuclear Compartmentalization and Architecture  
The contribution of lncRNAs in the building of a cell’s architecture is well known. A clear 
example comes from paraspeckles—ribonucleoprotein bodies found in the 
interchromatin space of mammalian cell nuclei—which play a central role in regulating 
gene expression during cell differentiation. These structures control many aspects of 
transcription and RNA processing, such as transcription initiation, coactivation and 
corepression, RNA splicing, and transcription termination, through retention of RNA in 
the nucleus (Bond & Fox, 2009). Given the large numbers of long noncoding transcripts 
currently being discovered through whole-transcriptome analysis, paraspeckles may be a 
paradigm for a class of subnuclear bodies formed around lncRNA.  
 
1.3.3- Cell Fate Specification  
It is well accepted that many lncRNAs provide an additional layer of regulation in the 
specification of cellular identities through the regulation of gene expression at 
transcriptional and translational levels (Hu et al., 2012). Recently, the muscle-specific 
lncRNA linc-MD1 was identified as a regulator of muscle cell differentiation (Figure 4), by 
acting as a competing endogenous RNA in mouse and human myoblasts. Downregulation 
and over-expression of linc-MD1 correlate with retardation and anticipation of the 
muscle differentiation program, respectively (Cesana et al., 2011).  
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Figure 4. Muscle-specific long noncoding RNA linc-MD1 as a sponge for miR-133 and miR-135. Legnini 
I. et al. describe alternative synthesis between linc-MD1 and miR-133 is controlled by the HuR 
protein, which favours linc-MD1 accumulation through its ability to bind linc-MD1. The author shows 
that HuR is under repressive control of miR-133 and that the sponging activity of linc-MD1 
consolidates HuR expression in a feedforward positive loop (Legnini et al., 2014).  
 
1.3.4- RNA Splicing and Translational Control  
Alternative splicing of pre-mRNAs increases the diversity of the proteome by generating 
different protein products having non-overlapping functions from a single mRNA. 
MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) was originally 
identified as a gene that was specifically upregulated in metastatic non-small cell lung 
cancer cells, but has subsequently been recharacterized as an lncRNA that accumulates 
in the nucleus and is now referred to as NEAT2 (nuclear-enriched noncoding transcript 2) 
(Hutchinson et al., 2007). This lncRNA regulates alternative splicing through its 
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interaction with serine-/arginine-rich (SR) nuclear phosphoproteins involved in the 
splicing machinery (Lin et al., 2011b).  
 
1.3.5- Chromatin Modification 
lncRNAs have been proposed to regulate transcription by recruiting chromatin-
remodelling complexes, which in turn mediate epigenetic changes. For example, 
Kcnq1ot1, Airn, Xist and HOTAIR are four lncRNAs that act to promote the formation of 
repressive chromatin structure across large genomic regions and even entire 
chromosomes (Figure 5). This is achieved through recruitment of epigenetic enzymes, 
such as polycomb repressive complex 1 (PRC1) and polycomb repressive complex 2 
(PRC2), which mediate mono-ubiquitinylation of lysine 119 on histone 2A and 
trimethylation of lysine 27 on histone H3, respectively (Pandey et al., 2008, Terranova et 
al., 2008). Another class of ncRNA that has received much emphasis is found expressed 
at enhancer regions: this type of RNA has been named enhancer RNA (eRNA). The size of 
eRNA ranges from 0.1 to 9 kb, comprising an average of 800 nt. Most promote 
transcription of neighbouring genes. An example is ncRNA-a7, which acts in cis to induce 
transcriptional activation of the nearby gene Snai1 (Orom et al., 2010). There are 
probably many other functions of lncRNAs awaiting discovery. For example, the lncRNA 
NRON has been shown to regulate nuclear trafficking of the transcription factor nuclear 
factor of activated T cells, and the observation that many lncRNAs are located in the 
cytoplasm suggests that they might have undiscovered roles in cell biology (Kapranov et 
al., 2007).  
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Figure 5. Chromatin modifiers in cis. (A) lncRNAs Kcnq1ot1, Air and Xist/Rep1 that are transcribed 
from the coding loci are accumulated on a chromatin in cis to recruit chromatin modifies. By 
modification of histones and DNA the modifiers facilitate the formation of the repressive chromatin. 
"Me" indicates methylation of a histone. (B) Chromatin modifiers in trans. HOXC locus express 
HOTAIR lncRNA that binds to the HOXD locus in trans and inactivates transcription by recruiting the 
chromatin modifiers to form the repressive chromatin. 
 
1.4- Molecular Mechanisms of lncRNAs  
The precise mechanism of how lncRNAs function still remains largely unknown and is the 
subject of intense investigation. Wang and Chang have proposed to classify the 
molecular mechanisms of lncRNAs into four main categories (Figure 6) (Wang & Chang, 
2011):  
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1.4.1- Signal lncRNAs  
These lncRNAs can serve as molecular signals because transcription of individual lncRNAs 
occurs at very specific times and places in order to interpret cellular context or to 
respond to diverse stimuli. For instance, Air and Kcnq1ot1 mediate the transcriptional 
silencing of multiple genes by interacting with chromatin and recruiting the chromatin-
modifying machinery (Mohammad et al., 2009, Wang & Chang, 2011).  
 
1.4.2- Decoy lncRNAs  
The molecular decoy type of activity takes place when specific lncRNAs are transcribed 
and then bind to and titrate away protein factors. Decoy lncRNAs can “sponge” protein 
factors such as transcription factors and chromatin modifiers. This leads to broad 
changes in the cell’s transcriptome. One of the most abundant nuclear lncRNAs in 
mammalian cells is NEAT2, which is localized in nuclear speckles. NEAT2 binds to and 
sequesters several SR splicing factors to nuclear speckles. Depletion of NEAT2 alters 
splicing-factor localization and activity, leading to an altered pattern of alternative 
splicing for a set of pre-mRNAs (Tripathi et al., 2010). In addition, lncRNAs can titrate 
microRNAs out from their target, functioning as competitive endogenous RNA (Cesana et 
al., 2011). 
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1.4.3- Guide lncRNAs  
These can act as molecular chaperons by localizing particular ribonucleoprotein 
complexes to specific chromatin targets. This activity can cause changes in the gene 
expression of neighbouring (cis) or distantly located (trans) genes that cannot be easily 
predicted by just the lncRNA sequence itself. Examples are HOTAIR and HOTTIP, both 
transcribed within the human HOX clusters. HOTTIP may organize chromatin domains to 
coordinate long-range gene activation by serving as key intermediates that transmit 
information from higher order chromosomal looping into chromatin modifications. In 
contrast, lncRNAs such as HOTAIR are able to alter and regulate epigenetic states in cells 
through their targeting of chromatin-modifying complex occupancy-localization- 
enzymatic activity in trans (Wang et al., 2011).  
 
1.4.4- Scaffold lncRNAs 
Some lncRNAs possess multiple domains that bind distinct proteins. The complexes 
formed perform functions such as transcriptional activation or repression. Thus, the 
lncRNA serves as an adaptor to form the functional protein complexes. The telomerase 
RNA TERC (TERRA), which is part of telomeric heterochromatin in addition to being 
present in the nucleoplasm, is a classic example of an RNA scaffold and is essential for 
telomerase function (Collins, 2008). 
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Figure 6. Molecular mechanism of long noncoding RNAs. (A) Signalling lncRNA: combination of 
lncRNAs and transcription factors may affect gene regulation; (B)decoy lncRNA: lncRNAs can displace 
transcription factors away from the chromatin, leading to the silencing of a nearby gene or (C) 
lncRNAs can titrate microRNAs out from their target; (D) guide lncRNA: lncRNAs may guide 
chromatin-modifying enzymes to their site of action, either in cis or in trans ; (E) scaffold lncRNA: 
lncRNAs can induce the assembly of multiple proteins affecting histone modifications. TF 
transcription factor, CME chromatin-modifying enzymes, RbNC ribonucleoprotein complexes. 
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1.5- Are lncRNAs Important Players of Heart Development?  
Over recent years, next-generation sequencing technologies have enabled the study of 
transcriptomes in various cell types at different developmental stages. These studies 
have revealed that the expression of many lncRNAs is regulated during development and 
that their role ranges from the control of pluripotency to lineage specification (Collins, 
2008, Kung et al., 2013, Lin et al., 2011a). For instance, XCI is tightly correlated with both 
early embryonic development and pluripotency in embryonic stem cells and induced 
pluripotent stem cells (Deuve & Avner, 2011). Knockdown of dozens of lncRNAs causes 
either exit from the pluripotent state or upregulation of lineage commitment programs, 
demonstrating that lncRNAs play key roles in the circuitry controlling the embryonic 
stem cell state (Guttman et al., 2011). The role of lncRNA in heart development is only 
starting to emerge. Indeed, two recent reports demonstrated that two lncRNAs, Fendrr 
and Braveheart (Bvht), are involved in defining the gene transcription program 
underlying the development of lateral mesoderm in heart and the differentiation of 
cardiomyocytes, respectively (Grote et al., 2013, Klattenhoff et al., 2013). Fendrr is 
specifically expressed in nascent lateral plate mesoderm and is required for the correct 
development of this tissue in heart and the body wall. Indeed, Fendrr-deficient mice die 
around E13.75 due to abnormal functioning of the heart. The heart of these mice 
presents with a thin ventricular wall, caused by cardiac hypoplasia linked to an altered 
proliferation of cardiac myocytes at later stages of heart development. Fendrr regulates 
the expression of important transcription factors, such GATA-6, NKX2-5, FOXF1, TBX3, 
IRX3 and PITX2, by controlling the epigenetic profile of the promoters of these genes. In 
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fact, Fendrr can bind either to PRC2 or to the Trithorax group/MLL protein complex 
(TrxG/MLL), which induces trimethylation of lysine 27—an H3 histone marker associated 
with transcription activation—and trimethylation of lysine 4 on histone H3—a marker 
associated with transcription activation—respectively (Grote et al., 2013). The lncRNA 
Braveheart (Bvht) is required for cardiomyocytes differentiation in vitro and for 
maintaining the cardiac phenotype in neonatal cardiomyocytes. Bvht is required for 
expression of core gene regulatory networks involved in defining cardiovascular cell fate 
and acts upstream of mesoderm posterior (MesP1), a master gene of cardiovascular 
lineage commitment. In a similar way to Fendrr, Bvht regulates cardiomyocytes 
differentiation by modulating the epigenetic profile of cells through interaction with 
SUZ12, a component of PRC2 (Klattenhoff et al., 2013). 
 
1.6- lncRNA: a Possible Player in Heart Failure  
If we are only at the beginning of understanding the role of lncRNA in heart 
development, we are even further away from comprehending the function of these 
molecules in cardiovascular disease. However, recent studies have started to investigate 
their role in this area. A genome-wide association study (GWAS) found six single-
nucleotide polymorphisms (SNP) in the lncRNA MIAT (myocardial infarction associated 
transcript) associated with myocardial infarction; one SNP (A11741G) caused a 1.3-fold 
increase in MIAT transcription in vitro (Ishii et al., 2006). Another study revealed 15 
lncRNAs modulated in the heart of mice subjected to aortic constriction—a procedure 
that, through the creation of pressure overload, induces first compensated hypertrophy 
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and then HF (Lee et al., 2011). Moreover, transcription in the heart of Kcnq1—a gene 
encoding a potassium channel—depends on the expression of the lncRNA Kcnq1ot1. This 
is an unspliced, ∼60 kb lncRNA whose transcription starts at intron 10 of Kcnq1 and in 
the opposite direction to that of the host gene. Mice that express a truncated Kcnq1ot1 
have an increased expression of Kcnq1. Because correct potassium channel activity is 
required for normal cardiac functioning, any alteration of the Kcnq1ot1-mediated control 
of Kcnq1 could be responsible for abnormal heart function (Korostowski et al., 2012). 
The involvement of lncRNA in HF is also suggested by the role of ANRIL (antisense 
noncoding RNA in the INK4 locus) in coronary heart disease (McPherson et al., 2007). 
This lncRNA is an antisense noncoding RNA transcribed with the INK4b– ARF–INK4a gene 
cluster, which encodes oncosuppressor proteins p15INK4b, p14 ARF and p16INK4a. 
GWAS revealed that many SNPs mapped to this genomic locus and, in particular, to the 
gene encoding ANRIL and were associated with increased susceptibility to coronary 
artery disease and several other diseases, including cancer. ANRIL regulates the 
expression of the INK4b–ARF–INK4a gene cluster through recruitment of both PRC1 and 
PRC2, promoting the formation of a repressive chromatin structure (Yap et al., 2010). In 
the light of these findings, it was proposed that loss-of-function mutations in this lncRNA 
lead to altered expression of p15INK4b, p14 ARF, and p16INK4a, influencing thus the 
susceptibility to coronary heart disease and cancer.  
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1.7- lncRNA: a Possible Therapeutic Target for Heart Failure?  
A therapeutic strategy for HF is to cure the sick heart cells by interfering with the gene 
expression program that underlies HF. To this end, novel therapeutic opportunities might 
arise from RNA-based strategies that consist in the use of synthetic RNAs capable of 
programming biological function. The potential of this strategy for HF is supported by the 
discovery of the role of miRNAs in triggering the gene expression program of HF and by 
the possibility of manipulating ncRNAs in vivo. Indeed, anti-miRNAs and antisense 
oligonucleotides are being employed to inhibit the expression of specific miRNAs in vitro 
and in vivo for investigative and clinical purposes (Care et al., 2007, van Rooij et al., 
2008). The use of the same strategies for lncRNA could open new therapeutic avenues 
for HF, overcoming problems linked to the use of miRNA-based molecules, such as low 
specificity and poor pharmacokinetics. Indeed, future studies on the role of lncRNA in HF 
and heart development will improve our understanding of the ncRNA network involved 
in regulating gene expression changes underlying HF and, thus, allow the development of 
specific therapeutic strategies based on the interference not only of miRNAs but also of 
lncRNA important for HF. These studies will greatly benefit from the combination of 
next-generation sequencing technologies applied to RNA (RNA-seq) with bioinformatics 
tools developed to identify lncRNAs that are differentially expressed in different 
biological conditions and for the prediction of their mechanism of action. Table 2 lists 
some bioinformatics tools used today to study lncRNAs. 
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1.8- Epigenetic 
The regulation of gene transcription in multicellular eukaryotic cells not only is driven by 
DNA elements that control gene expression (for example promoters and enhancer) but 
also by the state of chromatin in which the gene is localized (Birney et al., 2007). In this 
context, a mechanism that plays a crucial role is epigenetics, a complex network of 
mechanisms that control heritable gene expression without altering the primary 
nucleotide sequence. These mechanisms regulate gene expression by modulating 
chromatin structure and adjusting the biological processes that are the basis of gene 
expression (Care et al.). Epigenetic mechanisms are grouped mainly in four categories: 
DNA methylation, post-translational modifications of proteins histone, chromatin 
remodelling and small non-coding RNAs function as regulatory micro RNA (miRNA) and 
long non-coding RNAs (long non-coding RNA) (Figure 7) (Relton & Davey Smith, 2010). 
Many functional studies have shown how the epigenetic mechanisms play an important 
role in regulating the expression of genes involved in important biological processes such 
as cell differentiation, cell cycle and the DNA damage repair. So it is not surprising as 
epigenetic alterations are responsible for several human diseases such as cancer and 
some neuronal disorders such as Alzheimer's disease and Huntington's disease 
(Urdinguio et al., 2009).  
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Figure 7. Schema of principal mechanism of epigenetic regulation. 
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1.8.1- Chromatin Structure 
The entire genomic DNA of eukaryotic nuclei is organized into a highly compact structure 
called chromatin. It is made from DNA, small amount of RNA, and by two groups of 
protein molecules: histones and not histone proteins such as transcription factors, RNA 
polymerases, DNA polymerase and the topoisomerase. There are two types of 
chromatin: one that consists of thin filaments, called euchromatin and another one 
which is called heterochromatin. The euchromatin is characterized by an open 
conformation due to the relaxed nucleosomic state arrangement and a high flexibility, 
features that make the DNA accessible to proteins that regulate gene expression (Birney 
et al., 2007). The heterochromatin, however, is made up of portions temporarily 
(optional heterochromatin) or permanently (constitutive heterochromatin) very 
condensed. This feature makes the DNA inactive from transcriptional point of view being 
inaccessible to transcription factors. The heterochromatin in addition to having a role in 
the regulation of transcription also has a function to control the stability and protection 
from chromosomal mutations and translocations (Huang et al., 2004). This dynamic 
composition is regulated by multiple epigenetic mechanisms (Groth et al., 2007). The 
fundamental unit of chromatin is the nucleosome that consists of approximately 146 
base pairs of genomic DNA that wrap around an octamer of basic proteins, histones, 
called the "core histone". The nucleosome is the same type of organization in all 
eukaryotes. There are five types of histones: H1, H2A, H2B, H3 and H4. These, except 
histone H1, are present in equimolar amounts in the nucleosome (two histones of each 
class) and are arranged in an octamer composed of a tetramer of histones H3 and H4 
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histones of two dimers H2A-H2B. Histones are small basic proteins (the molecular weight 
is comprised between 11 and 20kDa), being rich in basic amino acids such as arginine and 
lysine. They are highly conserved from the evolutionary point of view and have a 
structure consisting of a carboxyl-terminal globular domain and amino-terminal end that 
protrudes from the nucleosome (called N-terminal tail). H1 is not part of the core 
histone, but seems to play an important role in inducing the chromatin to assume higher 
order structures. 
 
1.8.2- The Regulation of Chromatin  
The reorganization of chromatin superstructure allows the DNA to be suitably 
condensed, carefully replicated and ordered (Luger et al., 1997). Chromatin is a dynamic 
structure that can undergo strong conformational changes during DNA replication, gene 
expression, DNA repair and recombination events. The mechanisms that regulate the 
activity of chromatin are:  
• The reorganization of the nucleosome remodelling factors ATP-dependent. 
• The post-translational modifications of histones, creating a complex combination of 
signals that can activate or repress transcription, depending on the chemical nature of 
the molecule that makes the modification. 
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1.8.3- The Post-Translational Modifications of Histones 
Many studies have shown that combinations of post-translational modifications to level 
of the same histone or between different histones present in the same chromosome 
region constitute a "code", called epigenetic code that regulates many functions phones. 
The post-translational modifications of histones comprise methylation, acetylation, 
phosphorylation, ADP-ribosylation and ubiquitination (Fischle et al., 2003). Among these, 
the best known are acetylation and methylation. 
 
1.8.4- Acetylation of Histones H3 (H3ac) 
Acetylation is the addition of an acetyl group (-COCH3) group amino (NH2) present in the 
lysine residues of histones H3, H4, H2A and H2B. The acetylation is catalysed by histone 
acetyl transferase (Histone Acetyl Transferase, HAT), while the removal of the acetyl 
group is carried out by histone deacetylase (Histone deacetylases, HDAC) (Conerly & 
Grady, 2010). Genetic studies in combination with analysis of ChIP (chromatin 
immunoprecipitation) suggested that the opposing action of these two groups of 
proteins helps to maintain the equilibrium state of the level acetylation. Depending on 
the recruitment of HAT or HDAC on promoters determines a state of hyper or hypo-
acetylation correlated with activation or transcriptional repression, respectively. 
Acetylation, indeed, is a modification that promotes histone transcription through by 
promoting formation of a more open chromatin structure and therefore facilitating the 
binding of transcription factors on chromatin. Furthermore, the acetylation of lysines 
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determines a decrease of the positive charge on histone tails, which has the effect of 
reducing the affinity between adjacent nucleosomes. This event causes chromatin to be 
very dynamic and less condensed. (Ruthenburg et al., 2007).  
 
1.8.5- Methylation of Histone H3 (H3me) 
The methylation of histones involves the inclusion of one or more methyl groups (-CH3) 
to arginine and lysine on histone H3 and H4. Histone methylation, as acetylation, is a 
reversible process. In recent years, it has been identified several histone lysine 
methyltransferase (Lysine methyltransferase, KMT) and histone lysine demethylases 
(Lysine DeMethylases, KDM) (Black et al., 2012). From the functional point of view, if the 
acetylation of histones is always associated with transcriptional activation, the situation 
is different for methylation, which according to the methylated residue and the degree 
of methylation can promote transcriptional activation or repression (Figure 8). The 
methylation of lysine residues 4 and 79 of histone H3 are associated with transcriptional 
activation and lysine 9 and 27 residues on histone H3 promote transcriptional repression. 
Methylation also has different roles in regulation of transcription because each 
methylated residue is able to recruit specific proteins that can activate or repress 
transcription (Kouzarides, 2007). For example, the trimethylation of lysine 4 (K4) on 
histone H3 (H3K4me3) is a modification that promotes transcription through the binding 
of CHD1 (chromatin organization modifier), a transcription factor involved in 
transcription elongation and the processing of pre-mRNA. This histone modification is 
present on the promoter of transcriptionally active genes. An important aspect of the 
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regulation of gene expression by histone modifications is their interdependence that 
arises from the impossibility of two histone modifications to co-exist on the same amino 
acid residue and the ability to trigger different cellular signals according to the chemical 
group conjugated to the residue. For example, phosphorylation of serine 10 on histone 
H3 favours acetylation on lysine 9, preventing methylation of this residue. Lysine 9 
acetylation and methylation are associated with transcription activation and repression 
(Fischle et al., 2003). Many of the enzymes that modify histones post-translationally 
show a degree of specificity not only to a particular amino acid residue, but also to the 
state of histone modification of the existing one. 
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Figure 8. Distribution of histone modifications in active genes or silenced. In theFigure are 
schematized the nucleosome (A and C) and the distribution of changes in the gene (B e D). An active 
gene is displayed in (A) and (B). An external signal can lead to the activation of kinases (orange) in the 
nucleus, which phosphorylate (yellow circles) both histone and transcription factors (TF, red) to 
cause an appropriate physiological response. The transcription factor can bind to the promoter DNA 
to facilitate the docking of the RNA polymerase II (RNAPII, green) giving rise to the transcript. The 
elongation of RNA polymerase II to highly phosphorylated in the C-terminal domain, can interact, 
directly or indirectly, with histone modifiers (pink) (Kim et al., 2012). In particular, nucleosomes in 
promoter of transcriptionally active genes contain high levels of activators, such as acetylation and 
methylation of H3K4, creating a region of nucleosome depletion (NDR) in which bind the RNAPII. 
Inactive genes, shown in (C) and (D), have a regular distribution of changes in silencing, such as 
H3K9me2/3, while H3K27me3 is enriched in the promoter. These modifications constitute the 
binding site for heterochromatic proteins (blue) and which make the condensed chromatin and 
therefore transcriptionally inactive. 
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1.9- Enhancers 
The eukaryotic promoters immediately upstream of the transcription start site (TSS, 
transcription start site) are needed to establish the appropriate level of expression of 
genes. To express their function, the promoter sequence is assembled with a class of 
proteins known as transcription factors of polymerase II (TFII). The function of the trans-
agent of transcription factors is not exclusively related to the promoters, but often 
relates to other sites or distal cis-regulatory elements, which contribute to the 
modulation of transcription of genes located on the same DNA molecule. These elements 
are called "enhancers" or "silencers" depending on their function. They are able to 
operate regardless of orientation, position and distance, and contain sequences 
recognized by tissue-specific and/or inducible transcription factors. The enhancer and 
silencer may act on the promoter, increasing or inhibiting its activity through interactions 
with the basal transcription complex, or they can modify the chromatin structure so as to 
facilitate access or disadvantage of the complex transcription start on the DNA. 
Recently, genome-wide studies of the distribution of different histone modifications 
have shown that the enhancers have a specific epigenetic profile which allows not only 
the identification but also the prediction of their state of activities. The mono-
methylation of lysine 4 of histone H3 (H3K4me1) is considered a marker of enhancers, as 
it distributes much more at the level of these genetic elements than on the promoters. In 
contrast, H3K4me3 is largely absent at the enhancer, but is predominant at the 
promoters of active genes (Birney et al., 2007). It is possible to identify the putative 
enhancer through the analysis of the genomic distribution of these two types of histone 
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H3 methylation. This prediction becomes much more significant when the histone 
methylation markers are combined with other indicators of the activity of distal 
elements in specific cell types, such as the binding of the transcriptional cofactor p300, 
acetyl-transferase (Blow et al., 2010). In addition, other studies have shown that 
acetylation of histone H3K27 in combination with histone H3K4 mono methylation marks 
enhancers that distribute near active genes. Inactive enhancers called "poised", 
however, are associated with the presence of H3K4me1, combined with trimethylation 
of H3K27 and the absence of H3K27 acetylation (Rada-Iglesias et al., 2011). 
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AIM OF THE PROJECT 
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The aim of this project was to identify modulated protein coding genes and long-
intergenic noncoding RNA in order to study the development and progression of cardiac 
hypertrophy. To achieve this, we sequenced the transcriptome of isolated 
cardiomyocytes after 1, 2, 4 and 7 days of transverse aortic constriction and Sham-
operated mice as control. These data allowed us to determine networks and biological 
processes, important key genes, lncRNAs or novel lncRNAs involved in the pathology. We 
also analysed how promoter regions of protein coding genes and lncRNAs are regulated 
by transcription factors. Furthermore, to better understand the progression of the 
disease, we studied the fetal-like induced genes and lncRNAs involved in heart failure. 
The importance of this study lies not only in the furthering of our understanding of the 
pathological mechanisms leading HF, but aims to generate – in the light of recent 
progress in RNA-based therapeutic strategies – data that may be instrumental to the 
development of improved therapeutic strategies for this increasingly frequent pathology. 
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MATERIAL AND METHODS 
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2.1- Transverse Aortic Constriction  
To induce cardiac hypertrophy in mice, with subsequent heart failure, transverse aortic 
constriction is often used for its reproducibility and gradual time course. Initially, 
compensatory hypertrophy is associated with an enhanced cardiac contractility. Later, 
the hemodynamic overload became detrimental, causing cardiac dilatation and heart 
failure (deAlmeida et al., 2010)(Figure 9). 
According to the New Directive 2010/63/EU, special attention was paid to minimize 
animal suffering and welfare. During the procedure, anesthetized mice are closely 
monitored to assure that they were maintained in the proper anaesthetic plane. By 
pinching the tail of the animal while monitoring body temperature and respiratory rate is 
assessed the anaesthetic efficacy. Any reaction of the animal, hypothermia or increase in 
respiratory rate indicate that anaesthesia is too light and that should be given additional 
anaesthetic. All experiments were conducted in conformity with European Communities 
Council Directive. TAC surgery was adapted from Rockman HA et al (Rockman et al., 
1991). Briefly, C57Bl6/J mice were anesthetized by intraperitoneal injection of a mixture 
ketamine (100mg/kg) and xylazine (10 mg/kg). The mice were then placed in a supine 
position, and the chest was shaved using a chemical hair remover. The aortic arch was 
exposed through the 1st intercostal space. A 8-0 Prolene suture was passed between the 
truncus anonymous and the left carotid artery, a blunted 27-gauge needle was placed 
against the aorta and the knot tightened along with the needle and secured with a 
second knot. The needle was removed to create a lumen with a fixed stenotic diameter. 
The chest cavity was then closed with a 6-0 silk suture. A separate group of mice 
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underwent the same surgical procedure but without any tightening of the knot (sham 
group). The pressure load caused by the knot was verified through the measurement of 
the pressure gradient across the aortic constriction with echocardiography. The mean 
pressure gradient in TAC mice made to be approximately 70 mmHg in order to induce a 
rapid deterioration of heart function.  
 
 
 
Figure 9. The picture show the enlargement of ventricular walls caused by the transverse aortic 
constriction. 
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2.2- Cardiomyocytes Isolation 
The procedures used to obtain adult cardiomyocytes from sham- and TAC-operated 
mice, and for the culture of cardiomyocytes from neonatal mice, have been described 
elsewhere (Louch et al., 2011). 
 
2.3- RNA Extraction 
RNA was obtained from cells using TRIzol® reagent (Life Technologies®) following the 
manufacturer’s instruction. The process is divided in 4 steps. 
2.3.1- Sample Homogenization 
Cells were harvest by centrifugation and add to 0.75 mL TRIzol® Reagent per 0.25 mL of 
sample. Cells were lysed by pipetting up and down several times. 
2.3.2- Phase Separation 
Add 0.2 mL of chloroform to 1 mL of TRIzol® reagent and shake. The samples are then 
incubated for 2-3 minutes and centrifuged at 12.000 rpm for 15 minutes at 4°C degree. 
The aqueous phase, containing the RNA, were removed and dispensed in new tube. 
Then, add 0.5 mL of isopropanol to the aqueous phase, incubates for 10 minutes at room 
temperature centrifuge at 12.000 rpm for 15 minutes at 4°. 
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2.3.3- RNA Precipitation  
Add 0.5 mL of isopropanol 100% to the aqueous phase and incubate for 10 minute sat 
room temperature. Centrifuge at 12000 rpm for 10 minutes at 4°C. 
2.3.4- RNA Wash 
After the removal of supernatant, wash pellet with 1 mL of 75% ethanol, vortex and 
centrifuge for 5 minutes at 4°C. Repeat this procedure two times. At the end, resuspend 
the RNA in 20-25 µl of RNase-free water. 
 
2.4- Library Preparation and RNA-Sequencing  
The library was prepared following TruSeq Stranded Total RNA Sample Prep Guide 
(Illumina®). Briefly, after quality assessment of RNA integrity and purity with Bioanalyzer 
2100 (Agilent Technology, Inc), the RNA were depleted from ribosomal RNA fraction. 
Subsequently are synthetized the first and second strand of cDNA respectively. To ensure 
a low rate of chimera transcripts the 3’end are adenylated. At the end, multiple indexed 
adapter were ligated at the ends of ds-cDNA template and these molecules were then 
amplify through PCR. Finally were checked quality of the library with Bioanalyzer 2100. 
The RNA was sequenced with Illumina HiSeq 2000. Briefly, each fragment of RNA is 
bound randomly inside the surface of a flowcell and then amplified forming cluster of 
dsRNA. Then, for each cluster is read the incorporation of labelled nucleotides. This 
process generates an amount of sequences of nucleotide corresponding to the original 
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cluster; these sequence are then aligned to the genome to quantify the expression of the 
relative molecules.  
Below are show the number of reads generates for each samples (Table 2). 
Samples Total Reads Mapped Reads 
Sham Day1 Replicate1 52947412 47955356 
Sham Day1 Replicate2 59397336 52902223 
Sham Day2 Replicate1 56361481 50590870 
Sham Day2 Replicate2 60133321 53772985 
Sham Day4 Replicate1 55819479 50554195 
Sham Day4 Replicate2 57352629 50888211 
Sham Day7 Replicate1 56743781 48811810 
Sham Day7 Replicate2 52773918 46918196 
Tac Day1 Replicate1 65731893 59198328 
Tac Day1 Replicate2 59588156 53345326 
Tac Day2 Replicate1 53383412 48073849 
Tac Day2 Replicate2 51068134 45814014 
Tac Day4 Replicate1 57711882 51800046 
Tac Day4 Replicate2 58465497 52441887 
Tac Day7 Replicate1 51185723 45069530 
Tac Day7 Replicate2 55496080 48734104 
Embryonic Replicate 1 59677804 52744873 
Embryonic Replicate 2 62122420 55201554 
Pups Replicate 1 58629137 52636914 
Pups Replicate 2 61193627 55333980 
 
Table2. Table indicating the number of total sequenced reads and mapped read.  
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2.5- Alignment and Filtering 
The reads obtained from sequencing were aligned against the last Ensembl version of 
Mus Musculus genome (GRCm38_76) with Tophat (Trapnell et al., 2009, Langmead et al., 
2009). Tophat is a program that allow to aligns sequenced RNA reads in order to identify 
exon-exon splice junctions and to assign univocally the reads to a region of genome. It is 
built on the Bowtie (Langmead et al., 2009), ultrafast short read mapping algorithm. 
Briefly, the algorithm creates an index of the genome, by using Burrows-Wheeler 
transform (BWT) that allow to increase sensitivity and reducing time and memory 
calculation, and FM index with two novel extension for short reads alignment: a quality 
backtracking, to favours alignment with high quality and allow mismatch, and double 
indexing strategy to prevent excessive mismatching. Furthermore, as the transcripts 
coordinates are not continuative on the genome, the software is supply a reference 
annotation, that contain the relative coordinates of genes on chromosome, to help the 
reconstruction of the transcriptome (Langmead et al., 2009).  
Below, is the command used to align all the FASTA file, and list and the description of 
Tophat parameters used for the analysis (Table3). 
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Command Description 
-g 
Instructs TopHat to allow up to this many alignments to the reference 
for a given read, and choose the alignments based on their alignment 
scores if there are more than this number. The default is 20 for read 
mapping. Unless you use --report-secondary-alignments, TopHat will 
report the alignments with the best alignment score. If there are more 
alignments with the same score than this number, TopHat will 
randomly report only this many alignments. In case of using --report-
secondary-alignments, TopHat will try to report alignments up to this 
option value, and TopHat may randomly output some of the alignments 
with the same score to meet this number. 
-r 
This is the expected (mean) inner distance between mate pairs. For, 
example, for paired end runs with fragments selected at 300bp, where 
each end is 50bp, you should set -r to be 200. The default is 50bp. 
--mate-std-dev 
The standard deviation for the distribution on inner distances between 
mate pairs. The default is 20bp. 
-p Use this many threads to align reads. The default is 1. 
--library-type 
The default is unstranded (fr-unstranded). If either fr-firststrand or fr-
second strand is specified, every read alignment will have an XS 
attribute tag as explained below. Consider supplying library type 
options below to select the correct RNA-seq protocol. 
 Fr-Firststrand: we enforce the rule that the right-most end of the 
fragment (in transcript coordinates) is the first sequenced (or only 
sequenced for single-end reads). Equivalently, it is assumed that only 
the strand generated during first strand synthesis is sequenced. 
-G 
Supply TopHat with a set of gene model annotations and/or known 
transcripts, as a GTF 2.2 or GFF3 formatted file. If this option is 
provided, TopHat will first extract the transcript sequences and use 
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Bowtie to align reads to this virtual transcriptome first. Only the reads 
that do not fully map to the transcriptome will then be mapped on the 
genome. The reads that did map on the transcriptome will be 
converted to genomic mappings (spliced as needed) and merged with 
the novel mappings and junctions in the final tophat output. 
-o 
Sets the name of the directory in which TopHat will write all of its 
output. The default is "./tophat_out". 
 
Table3. List and description of parameters used for alignment. 
 
 
After alignment, the reads were filtered according to Phred quality score of 20. The 
filtering was performed with Samtools (Li et al., 2009) software for the manipulation of 
the alignment files. In the details the alignment files could be indeed in SAM format 
(sequence alignment map). These files contain not only the base composition of the 
reads and the chromosome coordinate at which it aligns, but also the quality score for 
each base called by sequencer and aligned. In this way is possible to extrapolate the 
desired information, or to filter out the low quality reads from the SAM file. 
Subsequently, to retrieve quantitative information, HTseq count software (Anders et al., 
2014) was used to count the aligned reads in the exonic region according to a list of 
genomic features. In details, the feature is an interval of coordinates on a particular 
chromosome. In this case the feature are the annotation of genes. With this software. 
the user has to pay attention in deciding how to act with reads that overlap more than 
one feature. The software allow 3 types of resolution mode (Figure 10): 
-union 
-intersect-strict 
-intersection-nonempty 
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Figure 10. Different possibility of association between the sequenced reads and the annotation. For 
each possibility is shown if gene reads is assigned to gene or not. 
 
To reduce the number of false positive assignments and increase sensitivity and 
sensibility, we decide to adopt the intersection-strict resolution. 
HT-seq count generates, as output, a table with the list of the feature (in this case the 
gene name) and the relative number of reads associated to them. 
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2.6- Differential Analysis 
The differential analysis was performed in R, a software environment for statistical 
computing and graphics (http://www.r-project.org/). EdgeR (Empirical analysis of digital 
gene expression data in R) (Robinson et al., 2010) package was used to analyse the 
modulated gene. Briefly, EdgeR uses empirical Bayes estimation and exact tests based on 
the negative binomial distribution; the row count are normalized on the total number of 
reads and log2 transformed. The significance threshold were set at pval<0.01 
(pval<0.001 for novel lincRNA).  
 
2.7- Novel lincRNA Discovery 
Cufflinks (Roberts et al., 2011, Trapnell et al., 2012) software was used to identify novel 
lincRNA. In particular, cufflinks is able to estimate the abundance of annotated 
transcripts but more important, is able to assemble novel islands of transcription in 
unannotated regions. To achieve this, Cuffcompare command was used to compare the 
transcribed region found on the experiment (based on RNA-seq evidence) to the 
annotation file and output the unannotated transcribed region. Subsequently on these 
regions, the number of reads were counted, normalized, transformed and analysed with 
EdgeR package to find modulated lincRNA across time and condition. Furthermore, was 
possible to reduce the number of false positives by intersecting the region actively 
transcribed (obtained from RNA Sequencing) with regions epigenetically regulated 
(obtained from Chip Sequencing) (Figure 11). 
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Figure 11. The picture shown how the region actively transcribed could be also epigenetically 
regulated. This combination could improve the discover and identification of novel lncRNAs. 
 
2.8- Encode 
The Encyclopaedia of DNA Elements (ENCODE; http://genome.ucsc.edu/ENCODE/) 
(ENCODE, 2012) Consortium is an international collaboration of research groups aimed 
to build a comprehensive parts list of functional elements in the human genome, 
including elements that act at the protein and RNA levels. From ENCODE, we 
downloaded from the University of Washington RNA-seq experiments performed on 
C57BL/6 mice at 8 weeks (http://www.washington.edu/). Each alignment file was 
convert into the most recent version of genome and annotation with CrossMap.py script 
(Zhao et al., 2014) and analysed with HT-seq count. 
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2.9- PhastCons 
Phast score of “phastCons60wayEuarchontoGlire” were downloaded from UCSC 
(http://genome.ucsc.edu/) and for each base-position of genes were calculated the 
relative conservation score. 
 
2.10- Coding Potential Calculation 
CPAT (Wang et al., 2013) software was used to calculate the coding potential for protein 
coding genes and lncRNA in order to assess their capacity to codify peptide and protein. 
Coding Potential Assessment Tool (CPAT) is able to recognize coding and noncoding 
transcripts from a large pool of candidates. To do this, CPAT uses a logistic regression 
model with 4 features: hexamer usage bias, open reading frame size, Fickett TESTCODE 
statistic and open reading frame coverage. 
 
2.11- IPA Analysis 
The networks, biological process, TOX and BIO function were generated through the use 
of QIAGEN’s Ingenuity Pathway Analysis (IPA®,QIAGEN Redwood City, 
www.qiagen.com/ingenuity). To perform the analysis we consider direct and indirect 
relationship among genes, by taking into account only experimentally observed 
interaction in mouse. Below are show the nodes and edges types legend for the 
comprehension of IPA networks. 
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2.12- Distribution of Pearson Correlation 
Person correlation is defined as the measure of correlation between two variables. In 
particular, the variable used in the experiments are the fold-change of lncRNA, and the 
fold change of protein coding genes. Due to the small dataset we decide to use the 
bootstrap methods, that is a statistical technique of resampling.  
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2.13- Heat Map 
Two-way hierarchical clustering of significantly modulated genes was performed with 
Cluster 3.0 software using gene-wise median-centred normalized intensities. Centred 
correlation and complete linkage clustering were used as the distance metric. Heat maps 
were visualized using Java TreeView software.  
 
2.14- cDNA Amplification and RT-PCR Analysis 
From total RNA we synthetized complementary DNA (cDNA) with High capacity cDNA 
reverse transcription kit (LifeTechnologies) following the manufacturer’s instructions. 
Briefly, total RNA (1μg) was mixed to a 10X RT Buffer (2μl), 25X dNTPS (0.8μl), 10X 
random primer (2μl), reverse transiptase (1μl), RNase inhibitor (1μl) and RNase-free 
water up to 20 μl. The mix was incubated in thermalcycler for: 
- 10 minutes 25° 
- 120 minutes 120° 
- 5 minutes 85° 
Then samples were stored at -80°. Validation were performed with RT-PCR using SYBR 
Master Mix on Viia7 Fast Real-Time PCR instrument (Applied Biosystem)Reaction 
contained 20 ng of cDNA, 1 μl of forward and reverse primer and 10ul of SYBR green 
master Mix. List of specific primer are provided below. 
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2.15- Chip-Seq Sequencing and Analysis 
ChIP was performed as described elsewhere (Peters et al., 2003). Briefly, the chromatin 
obtained from cardiomyocytes isolated from mice after 1 week of transverse aortic 
constriction (TAC) and from mice that were sham operated was sonicated to obtain an 
average chromatin length of 300bp. Immunoprecipitation was performed by incubating 
the chromatin at 4 °C overnight with antibodies against H3K9ac (ac, acetylation; K, lysine; 
H3, histone H3; Millipore-Upstate code: 07–352), H3K27ac (Abcamcode, ab4729), 
H3K4me3 (me, methylation; Active Motif code,39159), H3K79me2 (Abcam code, 
ab3594), H3K9me2 (Abcamcode, ab1220), H3K9me3 (Millipore-Upstate code, 07442), 
and H3K27me3 (Millipore-Upstate code, 07449). Then, ChIP DNA fragments were 
sequenced with the SOLiD system (Life Technologies) at Genomnia srl. ChIP DNA samples 
(5 ng) eluted in 50μL Tris-EDTA buffer (Tris·HCl 10mM, EDTA 1mM at pH 8) were sheared 
using the Covaris S2 System to reach a median size of 50-300bp. ChIP sequencing (ChIP-
seq) library preparation was performed according to the manufacturer’s protocol for 
5500 SOLiD ALPHA ChIP-seq Library Preparation (Life Technologies). Briefly, sheared 
samples were first end-repaired, modified by adding a poly-deoxy-adenylic acid-tail to 
their 3′ends, and ligated to specific SOLiD adaptors containing P1 and different barcode 
sequences. The nick-translated adaptor-ligated DNA was amplified using P1 and barcode 
primers, and after two Agencourt AMPure XP (Agencourt Bioscience Corporation) bead 
purifications steps, the yield and size distribution of the libraries were checked using the 
Agilent DNA 1000 Kit (Agilent Technologies, Inc.). Equal-molar barcoded libraries were 
pooled, and emulsion PCR was performed using the SOLiD EZ Bead system, according to 
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the manufacturer’s instructions. Sequencing was performed using standard settings on 
the 5500xl SOLiD Systems according to the 5500 Genetic Analysis System, Run sequencer 
protocol. At least 20 million tags for each library, 50 bp long, were sequenced. To profile 
histone modifications in cardiomyocytes, sequencing reads were mapped to the mouse 
genome(version mm9), using BOWTIE. Uniquely mapped reads with no more than 2 
mismatches were used for binding peak detection. To identify peaks, two software sets 
for peak calling were used: MACS (model-based analysis of ChIP-seq) and SICER (spatial 
clustering approach for the identification of ChIP-enriched regions). Both programs 
detected binding peaks by comparing IP with the input control. MACS and SICER were 
used with default parameters (Zang et al., 2009, Feng et al., 2012). Occupancy analysis 
and differential binding affinity analysis were assessed with the R Bioconductor package 
DiffBind (differential binding analysis of ChIP-seq peak data). The final set of binding 
peaks contained those that were identified by both software (Ross-Innes et al., 2012). 
Then the peaks were converted with UCSC liftover (http://genome.ucsc.edu/) in last 
version of genome coordinates. 
 
2.16- Project Pipeline 
Below is shown the pipeline used for the analysis. Briefly, starting from the alignment 
and differential analysis we were able to identify annotated lncRNA modulated. Starting 
from here, we determined the expression of nearby gene, that allowed us to find the 
modulated and enriched biological processes and networks, motifs enriched in promoter 
regions of lncRNAs and protein coding genes. Furthermore, Cufflinks modules, with the 
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application of different filter, and the intersection with epigenetic modification, allowed 
us to identify a set of novel modulated lncRNAs. 
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RESULTS 
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3.1- Hypertrophic Outcome 
To identify the lncRNAs modulated in cardiac hypertrophy, we carried out RNA-seq 
experiments on RNA purified from cardiomyocytes isolated from the left ventricle of 
mice that had been subjected to transverse aortic constriction (TAC), a surgical 
procedure that induces cardiac hypertrophy and then heart failure. Cardiomyocytes were 
isolated after 1, 2, 4, 7 days of TAC. The hypertrophy state was evaluated analysing the 
level of expression of several hypertrophy markers. Hypertrophic cardiomyocytes (Figure 
12 Panel a; *<0.05; **<0.01) had an increase (NPPA, NPPB, MYH7) or decrease (MYH6) 
according to hypertrophic outcome (Figure 12, Panel b). Furthermore, principal 
component analysis (PCA, Figure 12 Panel c), a statistical technique used to reduce the 
dimension of large datasets, performed on total RNA-sequenced, showed a high 
reproducibility between replicates and increased shifting of principal components after 4 
and 7 days of TAC surgery. 
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Figure 12. Panel a; RT-PCR analysis performed on hypertrophy markers (Nppa, Nppb, Myh7,Myh6). 
The picture shows the relative fold change ± SD, *<0.05; **<0.01. Panel b; phenotype of heart after 1 
week of constriction. Panel c; PCA plot. 
 
Then we identified lncRNA and protein coding genes expressed and modulated in TAC 
mice via RNA sequencing and row counts analysis. Massive parallel sequencing was used 
to retrieve paired-end and strand-specific reads of total RNA libraries of protein coding 
and lncRNA genes identified with the latest version of genome and annotation from 
Ensembl, together with edgeR analysis (R Bioconductor) to quantify the gene expression. 
The differential analysis identified at day1, 230 (156 up, 74 down); day2, 848 (334 up, 
514 down); day4, 1348 (968 up, 380 down); day7, 2259(1268 up, 991 down) modulated 
protein coding genes (Figure 13, Panel a). Regarding lncRNA, the analysis identified at 
day1, 12 (10 up, 2 down); day2, 28 (6 up, 22 down); day4, 35 (21 up, 14 down); day7, 64 
(18 up, 46 down) modulated lncRNAs (Figure 13, Panel b). These data underline a 
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correlation between the hypertrophic outcome and gene expression reprogramming not 
only for protein coding genes but also for lncRNA, suggesting that lncRNA could have an 
important role in the development and progression of cardiac hypertrophy. 
 
 
Figure 13. Panel a; Heatmap and Volcano Plot showing the number and level of modulated protein 
coding genes and, Panel b,. lncRNA. 
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In order to have information on the biological role of genes found modulated, we 
performed gene-gene network interaction analysis with IPA (Ingenuity Pathway 
Analysis). The first two days were characterized by networks for Energy Production and 
Metabolism (Day 1), as evidenced by up-regulation of Pdk4, a serine/threonine kinase 
that plays a key role in regulation of glucose and fatty acid metabolism, and thus 
involved in proliferation via its role in regulating carbohydrate and fatty acid metabolism 
(Zhao et al., 2008), and Acot2, an acyl-CoA thioesterase regulating intracellular levels of 
acyl-CoAs, free fatty acids and CoASH (Rame et al., 2011); on the other hand, Cell Death 
and Survival (Day2) processes were strictly related to cell cycle as indicated by the 
modulation of Lims2, involved in modulating cell spreading and migration, and Fstl1, 
involved in the modulation of the action of some growth factors on cell proliferation and 
differentiation. Next we found an enrichment of cardiac-specific networks 
(Cardiovascular Disease, Cardiac System Development and Cardiac Hypertrophy) starting 
from day 4, when the stress and the induced overload became deleterious. The up-
regulation of Nppa and Nppb, well-known hypertrophic markers, starts processes related 
to Cardiovascular Disease. Furthermore we observed a strong down-regulation of 
Angpt1, a regulator of endothelial cell survival, angiogenesis, migration, proliferation and 
maintenance of vascular quiescence, but also reorganization of the actin cytoskeleton. It 
is required for normal heart development and angiogenesis during embryogenesis. Day 7 
evidenced a stronger modulation of Nppa, Nppb and Myh7, involved in muscle 
contraction through interactions with actin-rich filaments that create a contractile force.  
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Figure 14. Gene-gene enriched network interaction obtained with IPA software. The colour gradient 
represent the level of modulation relative to the control. The red gradient is indicative if upregulation 
whereas the green gradient is indicative of downregulation. For more details about the legend see 
Material and Methods 2.11. 
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3.2- lncRNA in Cardiac Hypertrophy 
Next we characterized the nature of non-coding RNAs by assessing the mean level of 
transcription compared to protein coding genes, the conservation score (phastCons) and 
the coding probability. Figure 15, Panel a top, shows that lncRNAs and novel lncRNAs 
have a low level of transcription if compared to those of protein coding genes, 
suggesting that they may be involved in fine mechanisms of regulation. Furthermore, 
Figure 15, Panel a middle, shows that annotated and novel sequences of lncRNAs are not 
preserved between species if compared to exons of protein coding genes. An 
explanation for the low sequence conservation of lncRNAs and novel lncRNAs is that, to 
maintain their functionality, they do not require much nucleotide sequence 
conservation. Indeed, while protein coding genes are under very intense selection 
restraints to maintain correct amino acid coding, and thus their functionality, RNA 
molecules, that have much less rigid sequence requirements to maintain their secondary 
structures, only need short stretches of conserved sequences to maintain normal 
function (Louro et al., 2009, Mercer et al., 2009). Finally, Figure 15, Panel a bottom, 
shows that, according to their classification, lncRNAs and novel lncRNAs identified have a 
very low level of coding probability. 
Differential analysis identified a total of 108 time-dependent modulated lncRNAs (Figure 
15, Panel b and c); the Venn diagram shows that most lncRNAs are time-specific, 
suggesting that they could have specific roles at each time-point in regulating the change 
in gene expression. 
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Figure 15. Panel a top, Mean transcription of protein coding genes, lncRNAs and novel lncRNAs; 
middle Phast conservation score with Euarchontoglires; bottom, coding probability obtained with 
CPAT software. Panel b, Venn-Diagram of modulated lncRNAs at each time-point. Panel c, one-way 
hierarchical cluster analysis of modulated lncRNAs. 
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According to their genomic position, lncRNAs can regulate the expression of protein 
coding genes in cis (Figure 16, Panel a, b). Different mechanisms of regulation and 
interaction have been proposed (Figure 2 and Figure 6), but still no global properties 
have been identified for lncRNAs modulated in cardiac hypertrophy. To do this we 
correlated the level of modulation of 108 modulated lncRNA with those of the first five 
protein coding genes identified according to distance from the transcription start site 
(TSS). Moreover, to discriminate casual transcriptional clusters from a consistent 
association, we also checked the correlation between modulated protein coding genes 
and the nearby protein coding genes. Indeed, the maximum area included below the 
curves of Figure 16 panel d left, the x axis and the value of Pearson correlation of 0.5 is 
6.4% of the total. We set this percentage as the cut-off to determine possible positive 
correlation. Thus, by adopting this threshold, we determined a positive correlation 
between lncRNA and the first and second protein coding genes (Figure 16, Panel c). 
Figure 17 recapitulates all the annotated lncRNA modulated across time with a red or 
green bar indicating the value of fold change relative to the control. For each lncRNA, we 
also show the first two protein coding genes with their fold change. lncRNA were divided 
into clusters of regulation to better define and discover functionally associated lncRNA 
and protein coding genes (Figure 18). 
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Figure 16. Panel a, genomic position of lncRNAs, in ascending order, sense, intronic, bidirectional, 
exonic/intronic antisense, intergenic. Panel b, hypothetical way of mechanism of cis regulation. Panel 
c and d, left, whisker plot of distribution of Pearson correlation between lncRNA/protein coding 
genes and first five protein coding genes according to the TSS distance and right, relative frequency 
of Pearson correlation distribution. The percentage of areas included between the curves, x axis and 
0.5 cut-off of Pearson correlation are the following: for lncRNA/protein coding association, starting 
from the first genes, 60%, 12%, 0.8%, 0.08% and 0%. For protein coding/protein coding association 
are: 6.4%, 0.32%, 4.8%,0.12%,0.8%. 
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Figure 17. Summary of modulated lncRNA at each time point and first two nearby protein coding 
genes. Red and green bar represent the level of upregulation or downregulation respectively. 
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Figure 18.Cardiac related protein coding genes and lncRNAs. 
 
3.2.1-Enriched lncRNA Networks in Cardiac Hypertrophy 
The next step was to identify gene-gene network associations to better clarify the role of 
modulated IncRNAs and the associated protein coding genes. 
Ingenuity pathway analysis (Figure 19) was used to determine principal networks at each 
time-point. Day1 had networks related to Cell Function and Maintenance: the network 
identified modulation of Ak1, that catalyses the transfer of the terminal phosphate group 
between ATP and AMP, and thus is involved in cellular energy homeostasis; and Ucp3, a 
mitochondrial transporter protein that creates proton leaks across the inner 
mitochondrial, also involved in glucose homeostasis (Schrauwen et al., 2004). Day2 is 
enriched for Molecular Transport and Lipid Metabolism networks, as suggested by the 
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modulation of Abdh3, recently found to be a physiologic regulator of medium-chain 
phospholipids, and thus leading to greater energy expenditure (St-Onge & Jones, 2002, 
Long et al., 2011). 
As for the protein coding genes enriched network, Cardiac-related network started from 
day 4. Indeed, Corin, a serine-type endopeptidase involved in atrial natriuretic peptide 
hormone (NPPA) processing, was down-regulated. It has been demonstrated that Corin 
is a biomarker of hypertrophy (Gladysheva et al., 2013) and its regulation by lncRNA 
could help the understanding of how this gene is regulated in cardiac hypertrophy. 
Furthermore day 4 had down-regulation of Txnip, that may act as an oxidative stress 
mediator. Studies showed that cells that overexpress Txnip develop less hypertrophy 
after aortic constriction (Yoshioka et al., 2004) and thus the demonstration of a lncRNA-
dependent downregulation could improve our understanding of the involved network. 
Day 7 showed cardiac hypertrophy enrichment but also a re-expression of embryonic 
development-associated genes. For instance the up-regulation of Igf2r is involved both in 
embryonic maturation and cardiac hypertrophy. Moreover, Myocd, that plays a crucial 
role in cardiogenesis and differentiation of the smooth muscle cell lineage, is also an 
important modulator of cardiac hypertrophy (Kuwahara et al., 2010). 
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Figure 19. Gene-gene enriched network interaction obtained with IPA software. The colour gradient 
represents the level of modulation relative to control. The red gradient is indicative of upregulation, 
whereas the green gradient is indicative of downregulation. For more details on the legend see 
Material and Methods 2.11. 
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3.2.2-Enriched lncRNA Biological Processes in Cardiac Hypertrophy 
Furthermore we decided to elucidate the involvement of enriched biological process to 
better define the role of lncRNA and nearby protein coding genes. Analysis of Biological 
processes (Figure 20) showed a constant increasing of energy and morphological related 
process such as cardiogenesis, vasculogenesis and contraction of actin cytoskeleton. This 
is coherent with an increased energy requirement and the remodelling of the heart 
during cardiac hypertrophy. Furthermore specific biological processes are enriched only 
at days 4 and 7, such as fibrosis or cardiac hypertrophy. By contrast, a decrease in 
cardioprotection processes was observed during the development of cardiac 
hypertrophy, probably due to the increase of stress and hemodynamic overload. 
 
 
Figure 20. Heatmap of enriched biological processes for each day. Colour gradient represent the 
increase in significance, from green (less significant) to red (more significant) of the processes. 
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3.2.3- Cardiac Specific lncRNA 
Then we asked which modulated lncRNAs could have a heart- or cardiomyocyte-specific 
expression pattern. We downloaded RNA-seq expression data from the ENCODE project 
for different tissues (Figure 21, Panel a). By comparing the expression levels of 
modulated lncRNAs, it was possible to identify 6 cardiomyocyte-specific lncRNA (for 
instance Gm13054 and AU023070) and 25 heart-specific lncRNA (for instance Gm12167). 
These lncRNAs showed time-dependent correlation with the nearby (strongly heart 
related) genes (Figure 21, Panel b). For example Gm13054 correlated with the expression 
of NPPA and NPPB, natriuretic peptide (NP) receptors, playing a key role in 
cardiovascular homeostasis through regulation of natriuresis, diuresis, and vasodilation 
and inhibition of renin and aldosterone secretion. Moreover AU023070 showed a 
correlation with Corin, a serine-type endopeptidase involved in atrial natriuretic peptide 
hormone (NPPA) processing. It converts, through proteolytic cleavage, the non-
functional propeptide NPPA into the active hormone, thereby regulating blood pressure 
in heart and promoting natriuresis, diuresis and vasodilation. This suggests a fine 
regulatory mechanism that involves gene-gene and non-coding-gene interaction.  
Cyfip, nearby Gm12167, is involved in T-cell adhesion and p53/TP53-dependent 
induction of apoptosis, but its function remains largely unknown and in need of 
clarification. 
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Figure 21. Panel a: Two-way hierarchical cluster of expression values (normalized row counts) of 108 
modulated lncRNAs and various tissues downloaded from ENCODE. The yellow box evidence 
cardiomyocytes and heart specific clusters. Panel b, top, middle show two important cardiomyocyte 
specific lncRNAs and associated protein coding genes with consistent modulation through the time. 
bottom, heart specific lncRNA and associated gene. 
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3.3- lncRNA Modulated in Embryonic Maturation 
Cardiac hypertrophy is characterized by different mechanisms and processes that are 
activated by overload: for instance, signalling pathways, metabolic network that increase 
cell size, accumulation and assembly of contractile proteins and, in particular, an 
increase in the expression of embryonic genes (Hunter & Chien, 1999). Thus, we tried to 
quantify the disease-induced fetal-like changes in protein coding and lncRNA expression 
signatures. To do this, we sequenced RNA extracted from embryos after 14.5 days of 
maturation and performed differential analysis against adult mice (Sham 7 day). 
Differential analysis showed a huge number (545) of modulated lncRNA, suggesting that 
they play important roles not only in disease progression but also in specific processes 
and networks involved in cardiomyocyte maturation (Figure 22, Panel b). Furthermore 
biological enriched processes were significant with the nearby genes of lncRNAs partially 
resembling those found enriched for protein coding genes, such as Heart Development 
and Wnt Receptor Pathway, that regulate important aspects of organogenesis and cell 
fate determination during embryonic development (Komiya & Habas, 2008)(Figure 22, 
Panel a, b). The presence of lncRNA in this pathway strongly suggests that they may be 
fully involved in maturation of embryonic cardiomyocytes and thus plays an important 
role in these processes. 
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Figure 22.Panel a; two-way hierarchical cluster of expression values (normalized row counts) of 
modulated protein coding genes, volcano plot and barplot of enriched biological processes. A total of 
10293 (5757 upregulated and 4536 downregulated) protein coding genes were found modulated. 
Panel b; two-way hierarchical cluster of expression values (normalized row counts) of modulated 
lncRNAs, volcano plot and barplot of enriched biological processes. A total of 545 (239 upregulated 
and 305 downregulated) protein coding genes were found modulated. 
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3.3.1-TAC-Induced Fetal-Like Changes 
Next, to better define the role of lncRNA induced fetal like changes, we asked which of 
the upregulated and downregulated protein coding genes and lncRNAs were shared 
between embryonic and TAC-induced modulation, and which biological process were 
specific for each condition or shared between them. We found very specific enriched 
biological processes for embryonic and TAC conditions: Embryogenesis, Wnt pathway, 
Genomic imprinting and Muscle Morphology, Cardiac Tissue Morphogenesis (Figure 23). 
On the other hand, modulation of shared lncRNA enriched process involved both in 
embryonic maturation and in cardiac hypertrophy, such as Cell Proliferation and 
Cardiovascular Development. The same phenomena was observed for protein coding 
genes (Figure 23).  
Figure 24 summarizes lncRNA modulated both in embryonic and TAC condition with the 
nearby protein coding genes and the level of modulation. Furthermore panel b shows 
lncRNAs and probable nearby associated protein coding genes that resemble embryonic 
modulation in TAC-mice. Sema5a, which increases endothelial cell proliferation and 
migration, may promote angiogenesis and inactivation of this gene and results in 
embryonic lethality (Fiore et al., 2005); Eno3 has a function in striated muscle 
development and regeneration (Shi & Garry, 2006). 
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Figure 23. left, Venn diagram of upregulated (up) or downregulated (down) lncRNAs in 
Embryonic/Adult and Tac/Sham comparison. Bar plot shows enriched biological processes for specific 
Embryonic lncRNAs, common lncRNAs and TAC specific lncRNAs respectively. Right, Venn diagram of 
upregulated or downregulated protein coding genes in Embryonic/Adult and Tac/Sham comparison. 
Bar plot show enriched biological process for specific Embryonic, common and TAC specific protein 
coding genes, respectively. 
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Figure 24. Panel a: summary of TAC induced fetal like changes lncRNA and first two nearby protein 
coding genes. Red and green bar represent the level of upregulation or downregulation respectively. 
Panel b: lncRNA and nearby protein coding genes that resemble embryonic modulation in TAC mice. 
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3.4- Motifs Discovery 
To identify the transcription network within which the regulated promoters act to govern 
gene expression in TAC cardiomyocytes, we searched for the presence of transcription 
factor-binding motifs within -2000 kb from the TSS. RSAT (Regulatory Sequence Analysis 
Tools) identified conservative stretches of nucleotides shared between sequences 
recognized by transcription factors. The analysis revealed that promoter regions of 
protein coding genes are enriched for SP1 and KLF family transcription factors, both for 
TAC- and maturation-induced genes. Sp1 is a transcription factor that can activate or 
repress transcription in response to pathological stimuli and is involved in many 
processes such as apoptosis, cell growth, differentiation and immune responses. These 
data suggest that TAC-induced fetal-like reprogramming involves also transcription factor 
networks. On the other hand, specific transcription factors are enriched in promoter 
regions for modulated TAC or embryonic protein coding genes. Indeed, Mef2a and 
Mef2c transcription factors are induced only in TAC-modulated genes, suggesting that 
they may have a specific role in the development of hypertrophy (Passier et al., 
2000)(Figure 26, Panel b). Finally we validated the binding of SP1 to promoters of 
hypertrophy-modulated genes after 1 week of TAC surgery. (Figure 26, Panel c) 
Next we checked which transcription factors were present at the promoter region of 
lncRNAs. The analysis showed that lncRNAs are mostly regulated by their own 
transcription factor (in particular FOX related), that plays important roles in regulating 
the expression of genes involved in cell growth, proliferation, differentiation, and 
longevity. Fox related transcription factor seems to be specific for TAC-induce lncRNA.  
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Common transcription factor belong to the family of Arnt, that may form heterodimers 
with Ahr and Hif1a. Arnt::Ahr complex is involved in cell-cycle regulation and plays an 
important role in the development and maturation of many tissues. Arnt::Hif1a complex 
regulates the adaptive response to hypoxia and maintains biological homeostasis, 
influences cell metabolism, survival and angiogenesis (Alkon et al., 2012). Finally, 
embryonic-specific transcription factors belonged to the E2F family: these transcription 
factors are involved in cell cycle regulation and synthesis of DNA in mammalian cells 
(Figure 26, Panel a). 
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Figure 25. Panel a: enriched transcription factor binding motifs in modulated lncRNA promoters. 
Panel b: enriched transcription factor binding motifs in modulated protein coding genes promoters. 
Panel c. validation of Sp1 binding site in promoters of selected genes (Ndufa1, Cempf, Actrb3, Myl4). 
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3.5- Novel lncRNA 
Due to the difficulty in the discovery and identification of lncRNA, also the most recent 
version of genome and annotation may lack a complete definition of the lncRNA 
landscape. In particular this gap could be due to time-specific or tissue-specific 
expression of non-coding RNA. Thus, novel lncRNAs could play important and 
tissue/time-specific roles in a wide range of biological processes. To identify novel 
lncRNA we looked for islands of transcription in genomic regions lacking annotation. 
Then, different filters were applied to discriminate potential novel lncRNA from 
transcriptional noise. Each region was filtered according to their coding potential, 
number of exon, and to drastically reduce the number of false positive, we called 
enriched peaks of histone modification (see Material and Methods) between the 
condition and determined in this way which transcribed regions were also epigenetically 
regulated. We performed this analysis only at day 7, when we found the most gene 
expression reprogramming according to the hypertrophic response. Our analysis 
revealed 155 modulated novel lncRNA (68 upregulated and 87 downregulated). Gene-
gene interaction analysis showed an enrichment of Cardiac Hypertrophy and Cardiac 
Disease networks, consistent with day 7 hypertrophic outcome. Interestingly, we found 
new lncRNAs nearby Ankrd1 - a nuclear transcription factor that negatively regulates the 
expression of cardiac genes - and HOPX, required to modulate cardiac growth and 
development. The enriched biological processes were perfectly coherent with the 
outcome of hypertrophy after seven days of constriction. Indeed we found process 
related to energy and metabolism, to morphology and, in particular, hypertrophy-related 
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processes. Furthermore, motifs analysis revealed some binding sites of the annotated 
lncRNAs. Indeed Fox family binding sites were found enriched in the promoter regions of 
novel lncRNA.  
 
Figure 26. Panel a. Principle with it has been possible identify novel lncRNA transcribed and 
epigenetically regulated. Panel b: One-way hierarchical cluster of 158 row counts values of 
modulated novel lncRNA. Panel c: Network analysis. Panel d: enriched biological processes. Panel e: 
enriched binding motifs for promoter regions of novel lncRNAs. Panel f: novel lncRNAs that may 
regulates the expression of important cardiac related genes. 
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DISCUSSION AND 
CONCLUSION 
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Massive parallel, strand-specific and paired-end sequencing was used to identify 
modulated protein coding genes and modulated lncRNA after different time-points of 
hypertrophic stimuli. A number of modulated protein coding genes were strongly 
enhanced through time in response to the induced overload. We observed an 
enrichment of Energy Production and Metabolism and Cell Death and Survival networks 
in the first and second days, respectively. Important and specific gene networks were 
regulated at each day: for instance Pdk4, a regulator of glucose and fatty acid 
metabolism, and Acot2, an acyl-CoA thioesterase that regulates intracellular levels of 
acyl-CoAs, free fatty acids and CoASH, are modulated at day1; while Lims2, involved in 
modulating cell spreading and migration, and Fstl1, involved in cell proliferation and 
differentiation, are modulated at day 2. Cardiac specific networks become significant 
starting from day 4: Cardiac System Development, evidenced by upregulation of 
hypertrophic markers (Nppa, Nppb) and downregulation of Angpt1, a regulator of 
endothelial cell survival, angiogenesis, migration, proliferation and maintenance of 
vascular quiescence. TAC induced mice after 7 days showed a stronger upregulation of 
Nppa, Nppb and Myh7 that determine the hypertrophic response. 
Next we defined the signature of lncRNA modulated during the development of cardiac 
hypertrophy to better define the transcriptional landscape of this pathology. By 
assessing the mean level of transcription of lncRNA compared to protein coding genes, 
the conservation score (phastCons) and the coding probability, we characterized the 
nature of non-coding RNAs. Low level transcription of lncRNA relative to protein coding 
genes suggests that they may be involved in fine mechanisms of regulation. Furthermore 
both annotated and novel sequences of lncRNAs are not preserved between species as 
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they do not require much nucleotide sequence conservation to maintain their 
functionality. We show that most of lncRNAs are time specific, suggesting that they could 
have specific roles at each time point in regulating the change in gene expression.  
Furthermore we demonstrate a global correlation between the expression of lncRNA and 
the first two nearby genes. These genes were then used to perform gene-gene network 
analysis and biological process enrichment. As for protein coding genes, lncRNA are 
enriched for cardiac specific networks, starting from day4 with down-regulation of Corin, 
a serine-type endopeptidase involved in atrial natriuretic peptide hormone (NPPA) 
processing. The regulation of Corin by lncRNA could help to understanding how this gene 
is regulated in cardiac hypertrophy. After 4 days from TAC is also showed 
downregulation of Txnip. Cells that overexpress Txnip develop less hypertrophy after 
aortic constriction and thus the demonstration of a lncRNA-dependent downregulation 
could improve our understanding of the involved network. We observed both cardiac 
hypertrophy enrichment and re-expression of embryonic development associated genes 
after 7 days from TAC. Upregulation of Igf2r is involved both in embryonic maturation 
and cardiac hypertrophy. Moreover, Myocd, which plays a crucial role in cardiogenesis 
and differentiation of the smooth muscle cell lineage, is also an important modulator of 
cardiac hypertrophy. 
To better define the role of lncRNA and nearby protein coding genes, we performed 
gene ontology analysis to find out which biological processes were enriched. There was a 
constant increase of energy and morphological related processes, such as cardiogenesis, 
vasculogenesis and contraction of actin cytoskeleton. This suggests an important role of 
lncRNA in increased energy requirement and in the remodelling of the heart during 
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hypertrophy. Furthermore specific biological processes are enriched only at days 4 and 7, 
such as fibrosis or cardiac hypertrophy.  
By comparing the expression levels of modulated lncRNA in TAC mice with those 
obtained from different tissues downloaded from the ENCODE project, we identified 6 
cardiomyocyte-specific lncRNA (for instance Gm13054 and AU023070) and 25 heart-
specific lncRNA (for instance Gm12167). Moreover some of these lncRNAs show time-
dependent correlation with (strongly heart related) nearby genes: for instance Gm13054 
correlates with the expression of NPPA and NPPB, natriuretic peptide (NP) receptors 
playing a key role in cardiovascular homeostasis through regulation of natriuresis, 
diuresis, and vasodilation and inhibition of renin and aldosterone secretion respectively; 
AU023070 shows a correlation with Corin, a serine-type endopeptidase involved in atrial 
natriuretic peptide hormone (NPPA) processing. It converts, through proteolytic 
cleavage, the non-functional propeptide NPPA into the active hormone, thereby 
regulating blood pressure in heart and promoting natriuresis, diuresis and vasodilation. 
These data suggest that lncRNA may be expressed in specific tissues and time-points to 
regulate the stress response. 
As cardiac hypertrophy is characterized by the re-expression of embryonic genes first we 
decided to sequence RNA extracted from embryos after 14.5 days of maturation and 
performed differential analysis against adult mice (Sham 7-day) and compared the 
modulated lncRNA and protein coding genes with those modulated in TAC mice to find 
out which of these elements could play a role in maturation and disease. 
As we found a huge number of modulated lncRNA (545), we hypothesize that they play 
important roles not only in disease progression but also in specific processes and 
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networks involved in cardiomyocyte maturation. Furthermore, Heart Development, 
which regulates important aspects of organogenesis and cell fate determination during 
embryonic development, is biological enriched process both for protein coding genes 
and lncRNA. The presence of lncRNA in the Wnt Receptor pathway strongly suggests that 
they may be fully involved in maturation of embryonic cardiomyocytes and thus play and 
important role in this process. 
Next, we defined the role of lncRNA inducing fetal-like changes. We found specific 
enriched biological processes in embryonic and TAC conditions such as Embryogenesis, 
Wnt pathway, Genomic imprinting and Muscle Morphology, Cardiac Tissue 
Morphogenesis,. On the other hand, modulation of shared lncRNA is enriched in 
processes involved both in embryonic maturation and in cardiac hypertrophy, such as 
Cell Proliferation and Cardiovascular Development. Sema5a, that may promote 
angiogenesis, and Eno3, that has a function in striated muscle development and 
regeneration, are two important genes nearby lncRNA modulated both in embryos and 
the TAC condition. 
To identify the transcription network within which the regulated promoters acted to 
govern gene expression in TAC cardiomyocytes, we searched for the presence of 
transcription factor-binding motifs within -2000 kb from the TSS. We found specific 
transcription factors for promoters of protein coding genes and lncRNA. 
Promoter regions of protein coding genes are enriched for SP1, a factor that can activate 
or repress transcription in response to pathological stimuli and for KLF, involved in many 
processes such as apoptosis, cell growth, differentiation and immune responses, both for 
TAC- and maturation-induced genes. On the other hand, Mef2a and Mef2c transcription 
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factors are induced only in TAC-modulated genes, suggesting that they may have a 
specific role in the development of hypertrophy.  
lncRNA promoter regions are mostly regulated by their own transcription factor (in 
particular FOX related) that plays important roles in regulating the expression of genes 
involved in cell growth, proliferation, differentiation and longevity. Fox related 
transcription factor seems to be specific for TAC-induced lncRNA.  
Transcription factors shared between maturation and TAC mice belonged to the Arnt 
family, that may form heterodimers with Ahr and Hif1a. Arnt::Ahr complex is involved in 
cell-cycle regulation and plays an important role in the development and maturation of 
many tissues. Arnt::Hif1a complex regulates the adaptive response to hypoxia and 
maintains biological homeostasis, and influences cell metabolism, survival and 
angiogenesis. 
Novel lncRNA could play important and tissue/time-specific roles in a wide range of 
biological processes. We identify novel lncRNA by intersecting transcribed regions with 
those that were also epigenetically regulated. 
We found 155 modulated novel lncRNA (68 upregulated and 87 downregulated). Gene-
gene interaction analysis showed an enrichment of Cardiac hypertrophy and Cardiac 
Disease networks, consistent with day 7 hypertrophic outcome. Interestingly, we found 
new lncRNAs nearby two important genes: Ankrd1, a nuclear transcription factor that 
negatively regulates the expression of cardiac genes; and HOPX, required to modulate 
cardiac growth and development.  
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Furthermore, motifs analysis revealed some binding sites of the annotated lncRNAs. 
Indeed Fox family binding sites were found enriched in the promoter regions of novel 
lncRNA. 
Although these results do not elucidate the molecular mechanisms by which lncRNAs are 
involved in cardiac hypertrophy and heart development, the identification of a lot 
lncRNAs modulated in these biological processes suggests an important role of these 
regulatory molecules in heart physiology and pathophysiology. 
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